SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000905718-22-000425
Filing Date
2022-02-25
Accepted
2022-02-25 16:43:17
Documents
1
Period of Report
2022-01-31

Document Format Files

Seq Description Document Type Size
1 virpax_fm4ajan312022.html 4/A  
1 virpax_fm4ajan312022.xml 4/A 3946
  Complete submission text file 0000905718-22-000425.txt   5419
Mailing Address C/O VIRPAX PHARMACEUTICALS, INC. 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address
Chipman Christopher Michael (Reporting) CIK: 0001354941 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40064 | Film No.: 22681069

Mailing Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380 484-875-3195
Virpax Pharmaceuticals, Inc. (Issuer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations